Vulnerability Description
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
CVSS Score
MEDIUM
Related Weaknesses (CWE)
References
- https://aws.amazon.com/security/security-bulletins/2026-060-aws/
- https://github.com/awslabs/mcp/security/advisories/GHSA-6x7f-488g-75wm
- https://pypi.org/project/awslabs.aws-healthomics-mcp-server/0.0.36/
FAQ
What is CVE-2026-15415?
CVE-2026-15415 is a vulnerability with a CVSS score of 5.5 (MEDIUM). AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug ...
How severe is CVE-2026-15415?
CVE-2026-15415 has been rated MEDIUM with a CVSS base score of 5.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2026-15415?
Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.